We reasoned therefore that the enhanced T-cell infiltration in the tumour reflected not only the release of T cells from a PD-1-PDL1 checkpoint blockade, but also engagement of T cells with the increased MHC class I and class II expression. The gene discussed is HLA-C; the disease is neoplasm.